False Claims / Whistleblowers
July 21, 2014
The U.S. Department of Justice has filed a complaint against Midwest Neurosurgeons LLC and its owner, Dr. Sanjay Fonn, and DS Medical LLC and its owner, Deborah Seeger, for alleged violations of the False Claims Act and the Anti-Kickback Statute in connection with spinal implants and supplies used during surgeries performed by Dr. Fonn.
The Anti-Kickback Statute prohibits...
July 7, 2014
HSBC has agreed to pay $10 million to settle allegations that the company knowingly submitted or caused the submission of false claims to federal housing and mortgage programs, the U.S. Attorney’s Office for the Southern District of New York announced last week.
HSBC performs or oversees the performance of certain administrative activities in connection with residential...
Contract Fraud, False Claims Act, fannie mae, federal housing administration, Fraud Against Government, HSBC, Qui Tam, Whistleblower
July 2, 2014
Medtronic Inc. has agreed to pay $2.8 million to settle allegations that the company knowingly submitted or caused the submission of false claims to state Medicaid programs for replacement insulin infusion pumps, the Pennsylvania Attorney General’s office announced earlier this week.
Allegedly, Medtronic—doing business as Medtronic Diabetes—improperly...
False Claims Act, Fraud Against Government, healthcare fraud, Medicaid Fraud, Qui Tam, Whistleblower
June 25, 2014
Ohio-based Omnicare, the nation’s largest provider of pharmaceuticals and pharmaceutical services to nursing homes, has agreed to pay $124.24 million to settle allegations that the company knowingly submitted or caused the submission of false claims to federal health care programs, the U.S. Department of Justice announced today.
The settlement resolves allegations that...
False Claims Act, Fraud Against Government, Medicaid Fraud, Medicare Fraud, Qui Tam, Whistleblower, Whistleblower awards
June 23, 2014
Elizabethtown Hematology Oncology, PLC (EHO) and its owners have agreed to pay $3.7 million to resolve allegations that they knowingly submitted or caused the submission of false claims to federal health care programs Medicare, Medicaid, TRICARE, and the Federal Employee Health Benefit Program (FEHBP), the U.S. Attorney’s office for the Western District of Kentucky...
False Claims Act, Fraud Against Government, healthcare fraud, Medicaid Fraud, Medicare Fraud, Qui Tam, Whistleblower, Whistleblower awards
June 19, 2014
SunTrust Mortgage Inc. has agreed to pay $968 million to resolve False Claims Act violations in connection with mortgage origination, servicing, and foreclosure abuses, the U.S. Department of Justice announced earlier this week. About half, $418 million, resolve SunTrust’s liability; the rest will provide consumer relief for homeowners.
SunTrust admitted that...
June 3, 2014
Medtronic Inc. has agreed to pay the United States $9.9 million to resolve allegations under the False Claims Act that the company used various types of payments to induce physicians to implant pacemakers and defibrillators manufactured and sold by Medtronic, the Department of Justice announced late last month. Medtronic manufactures and sells medical products and is...
May 30, 2014
The United States filed a complaint against technology company CA Inc. for violating the False Claims Act, the Department of Justice announced yesterday. CA Inc. manufactures and sells information technology products and is headquartered in New York.
In its complaint, the government alleged that CA knowingly overcharged the government for software licenses and...
May 16, 2014
A lawsuit accusing OneWest Bank FSB, formerly known as IndyMac Bancorp Inc., of knowingly submitting or causing the submission of false claims to a federal mortgage program has been unsealed, Reuters reported. The U.S. government paid out over $200 million as a result of the alleged fraud.
The complaint was filed by Michael Fisher, who worked on modifications for OneWest...
April 22, 2014
Illinois-based Astellas Pharma has agreed to pay $7.3 million to resolve allegations that the company knowingly submitted or caused the submission of false claims in connection with the drug Mycamine, the U.S. Department of Justice announced last week.
The settlement resolves allegations that Astellas knowingly marketed and promoted the sale of Mycamine for pediatric use,...
False Claims Act, Fraud Against Government, healthcare fraud, Medicare Fraud, Qui Tam, Whistleblower, Whistleblower awards
Search Our Site
Subscribe to Our Blogs
Sign up for our newsletter to keep up-to-date with the latest important news from The Chanler Group
Contact Our Team
Use our online contact form, or visit our offices page for more details on how to reach us.
Want to apply for a grant? Check out our Grant Seeker FAQ.
If you want to contact a whistleblower attorney, please take a look at our Whistleblower Questionnaire.